基本資料
種類: ETF
費用比率%: 0.09
資產淨值: 6,452.81
成立日期: 26/01/2004
 
分析
市值分佈:
96.57%
大市值
2.18%
中市值
0.62%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 11/11/2026 04:01) 總持有投資項目: 410  
0%
 
100%
     10大 (51.75%)
代號 名稱 佔比% ▼ 持有日期
IDYAIDEAYA Biosciences0.0530/09/2026
OPCHOption Care Health0.0530/09/2026
DNTHDianthus Therapeutics0.0530/09/2026
ORKAOruka Therapeutics Inc0.0430/09/2026
AMRXAmneal Pharmaceuticals0.0430/09/2026
WAYWaystar Holding Corp0.0430/09/2026
ARQTArcutis Biotherapeutics0.0430/09/2026
KODKodiak Sciences0.0430/09/2026
CDNACareDx0.0430/09/2026
KNSAKiniksa Pharmaceuticals International, plc0.0430/09/2026
DNLIDenali Therapeutics0.0430/09/2026
LFSTLifeStance Health Group0.0430/09/2026
TMDXTransMedics Group0.0430/09/2026
NHCNational Healthcare Corp0.0430/09/2026
ATRCAtriCure0.0430/09/2026
ERASErasca0.0430/09/2026
NEOGNeogen Corp0.0430/09/2026
AMLXAmylyx Pharmaceuticals0.0430/09/2026
SLSSELLAS Life Sciences Group0.0330/09/2026
SUPNSupernus Inc0.0330/09/2026
  1    2    3    4    5    6    7   8    9    10    11    12    13    14    15    16    17    18    19    20    21  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.